Drugs / JNJ-89495120
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06785012 | Dec 2024 → Jun 2026 overdue | major depressive disorder | Janssen Research & Development, LLC | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-89495120 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06785012 ↗ |